Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 2/3 1

Status

Completed 69Recruiting 14Terminated 13Active not recruiting 8Unknown 6Withdrawn 3Not yet recruiting 2

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 145Thoracic 16Other solid neoplasm 6CNS 6Sarcoma 3Breast 3Plasma cell 1NET 1Gynecologic 1Endocrine 1Classical hematology 1

Conditions

Glioblastoma 3Glioma 2Rectal Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Gallbladder Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 66Radiotherapy 52Carboplatin 25Bevacizumab 21Cisplatin 19Radiosurgery 18Vincristine 17Etoposide 17Cyclophosphamide 17Surgical Procedures, Operative 13Magnetic Resonance Spectroscopy 13Chemotherapy, Adjuvant 11Melphalan 10Lomustine 10Drug Therapy 10Filgrastim 9Erlotinib Hydrochloride 9apatinib 8Pemetrexed 83-Iodobenzylguanidine 8anlotinib 7Radiation 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Thiotepa 6Isotretinoin 6Irinotecan 6Ifosfamide 6Doxorubicin 6Carmustine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Irinotecan × CNS × Clear all
NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

NCT02848794 2017-06-16

Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma

The First People's Hospital of Lianyungang

Phase 1/2 Unknown
40 enrolled
CNS

Glioma

NCT01535183 2014-07-14

Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents

Seoul National University Hospital

Phase 2 Unknown
40 enrolled
CNS

Brain Neoplasms

NCT01144988 2011-08-02

AVIRMA01-09

Medical University Innsbruck

Phase 2 Unknown
35 enrolled
CNS

Glioma

NCT01308632 2011-03-04

Metronomic Temozolamide in Patients With Recurrent Glioblastoma

Grupo Español de Investigación en Neurooncología

Phase 2/3 Unknown
30 enrolled
CNS

Glioblastoma

NCT00562419 2010-10-27

CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan

Adnexus, A Bristol-Myers Squibb R&D Company

Phase 2 Unknown
72 enrolled
CNS

Glioblastoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡